(Q43989079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Development of a nanocrystalline Paclitaxel formulation for HIPEC treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Pieter Colin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

4

Marc Bracke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Lieselotte De Smet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jan Van Bocxlaer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jean Paul Remon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Chris Vervaet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

4 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

2398-2406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555379%20AND%20SRC:MED&resulttype=core&format=json

Estimates of cancer incidence and mortality in Europe in 2008.

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

A new standard of care for the management of peritoneal surface malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Intraperitoneal antineoplastic drug delivery: rationale and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

The performance of expansile nanoparticles in a murine model of peritoneal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Targeted cancer therapy with novel high drug-loading nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

In vivo toxicity and bioavailability of Taxol and a paclitaxel/beta-cyclodextrin formulation in a rat model during HIPEC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Pluronic block copolymers for overcoming drug resistance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Drug delivery systems for intraperitoneal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Principles and practice of intraperitoneal chemotherapy for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0765-X

Nanosuspensions of poorly soluble drugs: preparation and development by wet milling

21 January 2018

1 reference

12 December 2020

Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications.

1 reference

12 December 2020

Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy

1 reference

12 December 2020

Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth

1 reference

12 December 2020